3. Old stuff
          3.1. Old pharm stuff (pre 2009)
              3.1.3. Pharmacology
                  3.1.3.2. Inhalational anaesthetic agents
                      3.1.3.2.5. Comparisons of inhalational agents
 3.1.3.2.5.5. Renal effects of inhalational anaesthetic agents 

Renal effects of inhalational anaesthetic agents

[SH4:p69]

Generic effects

  • All inhalational anaesthetic agents produce similar dose-related:
    * Decrease in renal blood
    * Decrease in GFR
    * Decrease in urine output
  • Prevented or lessened by preoperative hydration
  • Due to effects of inhalational anaesthetic agents on BP and cardiac output

Fluoride-induced nephrotoxicity

  • First recognised with methoxyflurane
    * Extensive metabolism (70%)
    * No renal effect when [F-]< 40microm/L
    * Subclinical when [F-] = 50-80
    * Clinical toxicity when [F-] > 80
  • Fluoride level alone is not an indicator for fluoride-induced nephrotoxicity
    * Lack of toxicity when [F-] >50 with ENF and sevoflurane
  • Fluoride interferes with enzymes in both proximal and distal tubules
  • Risk factor for enflurane nephrotoxicity (??? also true for other fluoride-induced nephrotoxicity)
    * Enzyme induction
    * Obesity
    * Preexisting renal dysfunction

Symptoms and signs of fluoride-induced nephrotoxicity

  • Polyuria
    * High output failure
    * ADH resistant [Edgar
  • Hypernatremia
  • Hyperosmolarity
  • Increased plasma creatinine
  • Inability to concentrate urine

Sevoflurane

  • Has not been shown to cause renal impairment
    * Despite peak plasma fluoride consistently higher than enflurane

Possible explanation

  • Intrarenal production of inorganic fluoride is more important for nephrotoxicity than hepatic metabolism
  • Plasma fluoride level is related to hepatic metabolism
  • Methoxyflurane and enflurane undergoes greater intrarenal metabolism

Vinyl halide nephrotoxicity

(i.e. compound A nephrotoxicity)

  • Sevoflurane reacts with carbon dioxide absorbents containing KOH and NaOH
    --> F+ and H+ removed
  • A few degradation products produced
    * Highest level is compound A (fluoromethyl-2,2-difluro-1-(trifluoromethyl) vinyl ether)

Compound A

  • Compound A is a dose-dependent nephrotoxin in rats
    --> Causes proximal tubular injury at 50 to 100ppm
    * LD50 in rats is 400pm for 3 hours
  • Production of compound A is higher when Baralyme is used
    * Probably due to higher absorbent temperature than soda lime
  • So far, it has not been demonstrated that compound A causes in human impairment of urine concentrating ability and plasma creatinine level.

Concentration of compound A in the circuit

  • At 1L/min, 19.7 ppm
  • At 3L/min, 8.1 ppm
  • At 6L/min, 2.1 ppm

Fresh gas flow of 2L/min is supposed to limit the concentration of compound A in the circuit

Probenecid

  • Selective inhibitor of organic anion transport
  • Prevents compound A-induced renal injury in rats

Mechanism of renal injury

  • Metabolism of compound A to a reactive thiol
    * Via the beta-lyse pathway
  • Human has less than 1/10 of the enzymatic activity in this pathway than rats

Halothane

  • Halothane also react with CO2 absorbent to form degradation products that are nephrotoxic to rats
  • But the product is les nephrotoxic than compound A